Triangle Insights Group Names New Partners

Triangle Insights Group, a strategy consulting firm advising life science leaders in pharmaceuticals, biotechnology, and related industries, has announced two new partners: Aileen Nicoletti, PhD, and Michael Turner. This move follows Triangle’s acquisition by Mercalis in April 2022.

Nicoletti, with more than 20 years of experience, specializes in portfolio and commercialization strategy for biotech and pharmaceutical clients. Her expertise includes new product planning, portfolio management, and brand and launch strategy. Nicoletti earned a BS in Chemistry from the College of William and Mary and a PhD in Biochemistry from the University of Michigan.

Turner brings more than 25 years of commercial strategy consulting experience in life sciences. He has advised biopharmaceutical companies on new product planning, commercial strategy, and portfolio strategy. Turner holds a BS in Operations Research and Engineering from Cornell University and an MBA from the University of Michigan’s Ross School of Business.

Chris Apolito, Founding Partner of Triangle Insights Group, stated in a news release: “The addition of Aileen and Michael further strengthens the Triangle and Mercalis leadership teams. Both individuals are highly respected in life sciences consulting, and I look forward to their contributions.”